Abstract
5-hydroxymethylcytosine (5hmC) is an oxidative derivative of 5-methylcytosine (5mC). Recent studies have revealed a sharp difference in the levels of 5hmC in 2 opposite DNA strands of a given chromosome and a chromosome-wide cell-to-cell variability in mammalian cells. This asymmetric 5hmC distribution was found in cultured cells, which may not fully mimic in vivo epigenetic processes. We have checked whether inter-chromosome and inter-cell variability of 5hmC patterns is typical for noncultured human cells. Using indirect immunofluorescence, we analyzed the localization of 5hmC and its co-distribution with 5mC on direct preparations of mitotically active cells from human embryonic lung and chorionic cytotrophoblast samples. We demonstrated 3 types of chromosomes according to the 5hmC accumulation pattern: hydroxymethylated (5hmC in both sister chromatids), hemihydroxymethylated (5hmC in only 1 sister chromatid), and nonhydroxymethylated ones. Each accumulation type was not specific to any particular chromosome, resulting in different 5hmC patterns between homologous chromosomes, among chromosomes within each metaphase plate, among metaphases in one tissue, and between the tissues. The 5mC distribution was stable: chromosomes were methylated in R-bands and, especially in embryonic lung cells, in the heterochromatic regions 1q12, 9q12, and 16q11.2. Our results provide the first evidence of inter-cell and inter-chromosome variability of 5hmC patterns in human noncultured embryonic and extraembryonic cells.
References
1.
Amouroux R, Nashun B, Shirane K, Nakagawa S, Hill PW, et al: De novo DNA methylation drives 5hmC accumulation in mouse zygotes. Nat Cell Biol 18:225-233 (2016).
2.
Arand J, Wossidlo M, Lepikhov K, Peat JR, Reik W, Walter J: Selective impairment of methylation maintenance is the major cause of DNA methylation reprogramming in the early embryo. Epigenetics Chromatin 8:1 (2015).
3.
Bachman M, Uribe-Lewis S, Yang X, Williams M, Murrell A, Balasubramanian S: 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat Chem 6:1049-1055 (2014).
4.
Baranov VS, Lebedev VM, Poleev AV, Mikhaĭlova EP, Rybalko AV, Shved NV: Fast direct method of obtaining metaphase and prometaphase chromosomes from chorion biopsy cells and human embryos during the 1st trimester of pregnancy. Biull Eksp Biol Med 110:196-198 (1990).
5.
Baranov VS, Pendina AA, Kuznetsova TV, Efimova OA, Fedorova ID, et al: Peculiarities of metaphase chromosome methylation pattern in preimplantation human embryos. Tsitologiia 47:723-730 (2005). [Article in Russian].
6.
Bogomazova AN, Lagarkova MA, Panova AV, Nekrasov ED, Kiselev SL: Reactivation of Х chromosome upon reprogramming leads to changes in the replication pattern and 5hmC accumulation. Chromosoma 123:117-128 (2014).
7.
Bolsheva NL, Gokhman VE, Muravenko OV, Gumovsky AV, Zelenin AV: Comparative cytogenetic study on two species of the genus Entedon Dalman, 1820 (Hymenoptera, Eulophidae) using DNA-binding fluorochromes and molecular and immunofluorescent markers. Comp Cytogenet 6:79-92 (2012).
8.
Branco MR, Ficz G, Reik W: Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13:7-13 (2011).
9.
Cimmino L, Aifantis I: Alternative roles for oxidized mCs and TETs. Curr Opin Genet Dev 42:1-7 (2017).
10.
Efimova OA, Pendina AA, Tikhonov AV, Kuznetzova TV, Baranov VS: Oxidized form of 5-methylcytosine-5-hydroxymethylcytosine: a new insight into the biological significance in the mammalian genome. Russ J Genet Appl Res 5:75-81 (2015a).
11.
Efimova OA, Pendina AA, Tikhonov AV, Fedorova ID, Krapivin MI, et al: Chromosome hydroxymethylation patterns in human zygotes and cleavage-stage embryos. Reproduction 149:223-233 (2015b).
12.
Efimova OA, Pendina AA, Tikhonov AV, Parfenyev SE, Mekina ID, et al: Genome-wide 5-hydroxymethylcytosine patterns in human spermatogenesis are associated with semen quality. Oncotarget 8:88294-88307 (2017).
13.
Efimova OA, Pendina AA, Tikhonov AV, Baranov VS: The evolution of ideas on the biological role of 5-methylcytosine oxidative derivatives in the mammalian genome. Russ J Genet Appl Res 8:11-21 (2018).
14.
Grigorian AS, Kruglyakov PV, Taminkina UA, Efimova OA, Pendina AA, et al: Alterations of cytological and karyological profile of human mesenchymal stem cells during in vitro culturing. Bull Exp Biol Med 150:125-130 (2010).
15.
Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H: The role of DNA methylation in setting up chromatin structure during development. Nat Genet 34:187-192 (2003).
16.
Hautefort A, Chesné J, Preussner J, Pullamsetti SS, Tost J, et al: Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. Oncotarget 8:52995-53016 (2017).
17.
Huh YH, Cohen J, Sherley JL: Higher 5-hydroxymethylcytosine identifies immortal DNA strand chromosomes in asymmetrically self-renewing distributed stem cells. Proc Natl Acad Sci USA 110:16862-16867 (2013).
18.
Inoue A, Zhang Y: Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 334:194 (2011).
19.
Ito S, Shen L, Dai Q, Wu SC, Collins LB, et al: Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333:1300-1303 (2011).
20.
Kantidze OL, Razin SV: 5-hydroxymethylcytosine in DNA repair: a new player or a red herring? Cell Cycle 16:1499-1501 (2017).
21.
Kokalj-Vokac N, Zagorac A, Pristovnik M, Bourgeois CA, Dutrillaux B: DNA methylation of the extraembryonic tissues: an in situ study on human metaphase chromosomes. Chromosome Res 6:161-166 (1998).
22.
Kol'tsova AS, Pendina AA, Efimova OA, Kaminskaya AN, Tikhonov AV, et al: Differential DNA hydroxymethylation in human uterine leiomyoma cells depending on the phase of menstrual cycle and presence of MED12 gene mutations. Bull Exp Biol Med 163:646-649 (2017).
23.
Kubiura M, Okano M, Kimura H, Kawamura F, Tada M: Chromosome-wide regulation of euchromatin-specific 5mC to 5hmC conversion in mouse ES cells and female human somatic cells. Chromosome Res 20:837-848 (2012).
24.
Li S, Zhu D, Duan H, Ren A, Glintborg D, et al: Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget 8:20656-20666 (2017).
25.
Li W, Liu M: Distribution of 5-hydroxymethylcytosine in different human tissues. J Nucleic Acids 2011:870726 (2011).
26.
Marcho C, Cui W, Mager J: Epigenetic dynamics during preimplantation development. Reproduction 150:R109-1R20 (2015).
27.
Mooijman D, Dey SS, Boisset JC, Crosetto N, van Oudenaarden A: Single-cell 5hmC sequencing reveals chromosome-wide cell-to-cell variability and enables lineage reconstruction. Nat Biotechnol 34:852-856 (2016).
28.
Nestor CE, Ottaviano R, Reinhardt D, Cruickshanks HA, Mjoseng HK, et al: Rapid reprogramming of epigenetic and transcriptional profiles in mammalian culture systems. Genome Biol 16:11 (2015).
29.
Patkin EL: Epigenetic mechanisms for primary differentiation in mammalian embryos. Int Rev Cytol 216:81-129 (2002).
30.
Patkin EL, Grudinina NA, Sasina LK, Noniashvili EM, Pavlinova LI, et al: Asymmetric DNA methylation between sister chromatids of metaphase chromosomes in mouse embryos upon Bisphenol A action. Reprod Toxicol 74:1-9 (2017).
31.
Pendina AA, Efimova OA, Kaminskaia AN, Kuznetsova TV, Baranov VS: Immunocytochemical analysis of human metaphase chromosome methylation status. Tsitologiia 47:731-737 (2005) [Article in Russian].
32.
Pendina AA, Efimova OA, Fedorova ID, Leont'eva OA, Shilnikova EM, et al: DNA methylation patterns of metaphase chromosomes in human preimplantation embryos. Cytogenet Genome Res 132:1-7 (2011).
33.
Pendina AA, Efimova OA, Chiryaeva OG, Tikhonov AV, Petrova LI, et al: A comparative cytogenetic study of miscarriages after IVF and natural conception in women aged under and over 35 years. J Assist Reprod Genet 31:149-155 (2014).
34.
Pfarr W, Webersinke G, Paar C, Wechselberger C: Immunodetection of 5′-methylcytosine on Giemsa-stained chromosomes. Biotechniques 38:527-528, 530 (2005).
35.
Pfeifer GP, Kadam S, Jin SG: 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 6:10 (2013).
36.
Razin A, Riggs AD: DNA methylation and gene function. Science 210:604-610 (1980).
37.
Schmid M, Steinlein C, Lomb C, Volleth M: Demonstration of 5-methylcytosine-rich DNA sequences in Chiroptera. Cytogenet Genome Res 152:38-45 (2017).
38.
Skryabin NA, Vasilyev SA, Lebedev IN: Epigenetic silencing of genomic structural variations. Russ J Genet 53:1072-1079 (2017).
39.
Suvorov A, Shershebnev A, Wu H, Medvedeva Y, Sergeyev O, Pilsner JR: Perinatal exposure to low dose 2,2',4,4'-tetrabromodiphenyl ether (BDE-47) alters sperm DNA methylation in adult rats. Reprod Toxicol 75:136-143 (2018).
40.
Szulwach KE, Li X, Li Y, Song CX, Han JW, et al: Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet 7:e1002154 (2011).
41.
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, et al: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-935 (2009).
42.
Tolmacheva EN, Kashevarova AA, Skryabin NA, Lebedev IN: Epigenetic effects of trisomy 16 in human placenta. Mol Biol 7:373-381 (2013).
43.
Vasilyev SA, Tolmacheva EN, Lebedev IN: Epigenetic regulation and role of LINE-1 retrotransposon in embryogenesis. Russ J Genet 52:1219-1226 (2016).
44.
Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, et al: Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149:1368-1380 (2012).
45.
Zheleznyakova GY, Nilsson EK, Kiselev AV, Maretina MA, Tishchenko LI, et al: Methylation levels of SLC23A2 and NCOR2 genes correlate with spinal muscular atrophy severity. PLoS One 10:e0121964 (2015).
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
